Which ETFs hold NEOPHARM CO LTD?
A092730 is held by 1 of the 504 ETFs we cover. The heaviest allocation is SPDW at 0.0%. The median weight across all funds holding it is 0.0%.
- Covered ETFs Holding It
- 1
- Heaviest Allocation
- 0.00%in SPDW
- Median Weight
- 0.00%across funds that hold it
Funds Holding A092730(1)
| ETF | |||||||
|---|---|---|---|---|---|---|---|
| SPDWState Street® SPDR® Portfolio Developed World ex-US ETF | 0.00% | 0.03% | $40.5B | 2.94% | +17.9% | +30.1% | +10.1% |
Expense = net expense ratio from the fund's latest SEC prospectus filing. YTD/1Y/5Y are trailing total returns including dividends (5Y annualized, as of 2026-08-07). Past performance does not predict future results. Sort by any column.
Frequently Asked Questions
Which ETF has the most A092730 exposure?
SPDW has the heaviest A092730 allocation of the ETFs we cover, at 0.00% of its portfolio, based on the fund's latest SEC-reported holdings.
How many ETFs hold A092730?
1 of the 504 ETFs we cover hold NEOPHARM CO LTD (A092730). The median weight across those funds is 0.00%.
What is the cheapest ETF that holds A092730?
SPDW has the lowest expense ratio among covered ETFs holding A092730, at 0.03% per year.
What is the largest ETF that holds A092730?
SPDW (State Street® SPDR® Portfolio Developed World ex-US ETF) is the largest covered ETF holding A092730, with $40.5B in assets and a 0.00% position.
Keep Exploring
Look up another stock or compare two of these ETFs to see how much they overlap beyond A092730.